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Background: The global spread of bacterial resistance has given rise to a growing interest in new anti-bacterial
agents with a new strategy of action. Pilicides are derivatives of ring-fused 2-pyridones which block the formation
of the pili/fimbriae crucial to bacterial pathogenesis. They impair by means of a chaperone-usher pathway
conserved in the Gram-negative bacteria of adhesive structures biogenesis. Pili/fimbriae of this type belong to two
subfamilies, FGS and FGL, which differ in the details of their assembly mechanism. The data published to date have
shown that pilicides inhibit biogenesis of type 1 and P pili of the FGS type which are encoded by uropathogenic
E. coli strains.
Results: We evaluated the anti-bacterial activity of literature pilicides as blockers of the assembly of a model
example of FGL-type adhesive structures, – the Dr fimbriae encoded by a dra gene cluster of uropathogenic
Escherichia coli strains. In comparison to the strain grown without pilicide, the Dr+ bacteria cultivated in the
presence of the 3.5 mM concentration of pilicides resulted in a reduction of 75 to 87% in the adherence properties
to CHO cells expressing Dr fimbrial DAF receptor protein. Using quantitative assays, we determined the amount of
Dr fimbriae in the bacteria cultivated in the presence of 3.5 mM of pilicides to be reduced by 75 to 81%. The
inhibition effect of pilicides is concentration dependent, which is a crucial property for their use as potential
anti-bacterial agents. The data presented in this article indicate that pilicides in mM concentration effectively inhibit
the adherence of Dr+ bacteria to the host cells, – the crucial, initial step in bacterial pathogenesis.
Conclusions: Structural analysis of the DraB chaperone clearly showed it to be a model of the FGL subfamily of
chaperones. This permits us to conclude that analyzed pilicides in mM concentration are effective inhibitors of the
assembly of adhesins belonging to the Dr family, and more speculatively, of other FGL-type adhesive organelles. The
presented data and those published so far permit to speculate that based on the conservation of chaperone-usher
pathway in Gram-negative bacteria , the pilicides are potential anti-bacterial agents with activity against numerous
pathogens, the virulence of which is dependent on the adhesive structures of the chaperone-usher type.Background
Bacterial pathogenesis is a complex process which has
been well studied in the case of urinary tract infections
(UTIs) mediated by uropathogenic Escherichia coli
(UPEC) expressing type 1 and P pili. The crucial steps of
this mechanism, namely, initial bacterial attachment,* Correspondence: rafpiate@pg.gda.pl
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reproduction in any medium, provided the orinvasion and biofilm formation, are strictly dependent on
the pili function [1,2]. These structures belong to the family
of adhesive organelles assembled in accordance with the
classical chaperone-usher pathway, which is highly con-
served in Gram-negative bacteria. Pili, fimbriae or amorphic
adhesive oganelles are linear homo- or heteropolymers of
hundreds to thousands of protein subunits. All these pro-
teins possess a conserved immunoglobuline-like structure
denoted by the lack of the seventh β-strand, G. The effect
of this structural defect is a hydrophobic acceptor cleft
flanked by the β-strands A and F [3-6]. The folding oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the specific periplasmic chaperone protein. The
chaperone complements the defective structure of a
subunit by donating a specific G1 donor β-strand in line
with the donor strand complementation (DSC) reaction
[5-8]. The stable chaperone-subunit complex migrates
to the usher protein located in the outer membrane,
where the process of protein subunit polymerization oc-
curs. The formation of the functional adhesive organelle
propagates in accordance with the donor strand ex-
change (DSE) reaction This step is dependent on the ac-
tion of the N-terminal donor peptide exposed from each
subunit [9-11].
Though global conservation of chaperone, usher and fim-
brial proteins, the available structural data describing the
assembly of different adhesive organelles, namely, P and
type 1 pili of E. coli, F1 surface antigen of Y. pestis, Dr/Afa-
III fimbriae of E. coli, SAF fimbriae of S. typhimurium and
colonization factor CS6 of E. coli, also identify many im-
portant differences between them [12-14]. The specific
structural and functional adaptations connected with the
biogenesis of particular adhesive structures have been well
studied in the case of chaperone and subunit proteins. Se-
quence and structural data comparisons allow the family of
periplasmic chaperones to be divided into two subfamilies
on the basis of the length of the loop connecting β-strand
F1 with the donor G1 strand, the FGL and FGS subfamilies
having a long and a short loop, respectively [15,16]. This
loop is an important structural element which, in the
chaperone-subunit complex, extends the acceptor cleft
binding motif of the chaperone G1 donor strand. In the
FGS chaperones, the β-strand G1 stabilizes a subunit core
by donating only three bulky hydrophobic residues [4,7]. In
the case of FGL chaperones, the G1 binding motif is typic-
ally extended by two additional, bulky, alternating hydro-
phobic residues from a loop region [5,13]. In the FGL
chaperones, the second subunit-binding motif involved in
the DSC mechanism is formed by three bulky hydrophopic
residues located in the long N-terminal sequence forming
the β-strand A1 [5,13]. The long F1-loop-G1 hairpin of
these chaperones is stabilized by the disulfide bond con-
served in the whole subfamily [17,18]. The longer G1 and
A1 binding motif of the FGL chaperones correlates with
the extended structure of the subunits’ acceptor cleft [13].
The molecular differences in the structure and function of
the FGL and the FGS chaperones presented here correlate
with the structure of the adhesive organelles which they as-
semble [13]. The FGL chaperones assemble organelles
composed of only one type of protein subunit and, option-
ally, the second minor tip subunit [12,13]. They are charac-
terized by a thin fimbrial, amorphous or capsule-like
morphology. Each subunit of these homopolymeric struc-
tures possesses the host-cell receptor binding site or sites;
thus, they are polyadhesins. In contrast, the FGSchaperones assemble heteropolymeric, well-structured ad-
hesive pili composed of up to seven different subunits
[10,19]. Pili are monoadhesins, as they possess only one
receptor binding subunit located at the tip of the organelle.
In addition, the division of chaperones and adhesive organ-
elles into the FGS and FGL families also correlates with the
phylogenetic analysis based on the usher ancestry. The FGL
organelles belong to the γ3-monophyletic group, while the
FGS can be divided into five clades: γ1, γ2, γ4, κ and π [20].
The adhesive organelles of the chaperone-usher type
are unique virulence factors specific only to Gram-
negative -pathogenic bacteria. The conservation of this
mechanism renders it a good potential target for the de-
velopment of antibacterial agents [21,22]. The pilicides
originally proposed by Svensson et al. in 2001 are a class
of low molecular weight agents, derivatives of a dihy-
drothiazolo ring-fused 2-pyridone scaffold which block
formation of pili by affecting the function of chaperone
[22]. According to the crystallographic and biological
data, pilicides target the chaperone-usher pathway by
blocking interaction between the N-terminal domain of
the usher and chaperone-subunit complex. Hence, the
pilicides block the formation of pili by preventing a DSE
reaction. Pilicides bind to the hydrophobic patch of resi-
dues located in the F1, C1, D1 region of the N-terminal
domain conserved in all chaperones [23]. This region
encompasses part of the F1-G1 loop which is structur-
ally rearranged during the formation of the chaperone-
subunit complex (DSC reaction). The dynamic nature of
this region is also reflected in the pilicide binding modes
observed in the crystal structures of the pilicide in the
complex with a free PapD chaperone or the PapD-PapH
complex [23,24]. Although, pilicide interactions with
conserved I93, located at the end of the β-strand F1,
with L32 and with the V56 patch are preserved in these
two structures, the electrostatic interactions between
R96, located within the loop F1-G1, and R58 residues
and carboxyl and carbonyl groups of pilicide are broken
as a consequence of the PapH binding to the PapD [24].
The important differences in the structure of the F1-G1
hairpin and the mechanism of DSC reaction observed
between the FGS and FGL assembly systems might po-
tentially affect pilicide binding. This gives rise to the
question as to whether pilicides that were originally
designed on the basis of the structure of the FGS-type
PapD and FimC chaperones and were evaluated as in-
hibitors of the biogenesis of the P and type 1 pili are also
active in respect of the FGL assembly pathway.
In this study, we addressed a question denoting the activ-
ity of pilicides as inhibitors of the assembly of the Dr
fimbriae encoded by the dra operon of uropathogenic
E. coli - the model of the FGL-type adhesive structures
[25,26]. These organelles are homopolymers of a single
DraE subunit, the structure of which has three receptor
Piatek et al. BMC Microbiology 2013, 13:131 Page 3 of 12
http://www.biomedcentral.com/1471-2180/13/131binding sites interacting with the following host-cell mole-
cules: Dra blood-group antigen presented on the CD55/
decay-accelerating factor (DAF), the carcinoembryonic anti-
gen (CEA)-related cellular adhesion molecules and the 7S
domain of basement membrane protein type IV collagen
[27-29]. The assembly of Dr fimbriae is dependent on the
action of the DraB chaperone and the DraC usher [17]. The
data presented in this article are also important from the
epidemiology point of view, as uropathogenic E. coli Dr+
strains are responsible for 20–25% of cases of cystitis and
30% of pyelonephritis in pregnant woman [30].
Methods
General synthesis of pilicides
The reagents were purchased from Sigma-Aldrich. The
analytical TLC was performed on aluminum sheets of
silica gel UV-254 (Merck). The flash chromatography
was carried out using Zeochem silica gel with particle
size of 40–63 microns. The NMR spectra 1H and 13C
were recorded at Varian Gemini 200 and Varian Unity
Plus 500 in CDCl3 or DMSO. The melting points are
uncorrected. Pilicides 1 and 2 were prepared in accord-
ance with previously published procedures [22,31].
Given the poor water solubility of the acidic forms of
these pilicides, their lithium salts were used in all the ex-
periments. The resulting solutions of compounds were
frozen and lyophilized. In order to conduct the experi-
ments, the pilicides were initially dissolved in pure
DMSO and the final concentration of DMSO in the
growth media was 5%.
Statistical analysis
In the case of E. coli Dr+ strain adherence to CHO cells
assay and collagen binding assay the statistical signifi-
cance of results was tested using one-way ANOVA (p-
value threshold = 0.05). Influence of pilicides 1 and 2
concentration on the bacterial adherence to CHO cells
was assessed relatively to positive control means experi-
ments with adherence of BL21DE3/pBJN406 strain culti-
vated without pilicide to CHO-DAF+ cells. Influence of
pilicide 1 concentration on bacterial binding to the poly-
styrene microtitre plates coated with type IV collagen
was assessed relatively to positive control means experi-
ments with BL21DE3/pBJN406 strain cultivated without
pilicide.
Bacterial strains and plasmids
The following E. coli strains were used: BL21DE3/
pBJN406 – the strain encoding within the pBJN406 plas-
mid the wild type dra operon from the clinical UPEC
IH11128 strain, the plasmid is a derivative of the
pACYC184 vector; BL21DE3/pACYC184 – a strain used
as Dr-type, non-fimbriated, negative control [26,32]. In
order to select for the presence of these plasmids,bacteria were grown on media supplemented with chlor-
amphenicol at a concentration of 34 μg/ml.Assay of E. coli Dr+ strain adherence to CHO cells
CHO cells (Chinese hamster ovary K-1) and CHO-DAF+
cells stably transfected with cDNA for human DAF [33]
were cultured in Ham’s F12 medium supplemented
with 10% (vol/vol) fetal bovine serum (Sigma) and a
penicillin-streptomycin solution (Sigma) in a 5% CO2 at-
mosphere at 37°C. The cell lines were passaged using
0.25% (vol/vol) trypsin containing EDTA (Sigma). For the
adherence assay, the CHO-DAF+ and the CHO-DAF- cells
were split into 6-well plates with glass coverslips, and
grown in the appropriate medium for 18 h. Before the
assay, the CHO cells were washed twice with phosphate
buffered saline (PBS) and incubated with fresh medium,
without antibiotics and without FBS for 1 h. The E. coli
BL21DE3/pBJN406 strain was cultivated with shaking in
Luria-Bertani (LB) medium, supplemented with chloram-
phenicol, for 24 h at 37°C. 100 μl of the bacterial culture
was then split on TSA (trypticase soy agar) plates
containing 5% DMSO, chloramphenicol and either sup-
plemented or not with 0.5, 1.5, 2.5 and 3.5 mM pilicide 1
and 2 for another 24 h at 37°C. As the negative control
the E. coli BL21DE3/pACYC184 strain cultivated on TSA
plates not supplemented with pilicides was used. The
overnight bacterial strains were harvested from plates
washed twice with PBS and resuspended in this buffer to a
final OD600 of 1.5. 50 μl of each of the E. coli bacterial
strain suspensions were added to the 4 wells containing
the CHO-DAF+ or CHO-DAF- cells grown on glass cover-
slips and incubated for 1.5 h at 37°C. The wells were then
washed three times with PBS, fixed with 70% methanol
and stained with 10% Giemsa in order to visualize the
bound bacteria. Finally, the glass coverslips were examined
for bound bacteria under an Olympus inverted micro-
scope (CKX41) with phase-contrast objective. From each
coverslip 40 CHO cells were examined and associated bac-
teria were counted. For each combination of the bacterial
strain and CHO cell culture three independent experi-
ments were carried out. To avoid experimenter random
errors each experiment was performed using fresh bacter-
ial transformants, fresh CHO cells cultures and fresh prep-
aration of growth media. In all experiment for each
combination of the bacterial strain and CHO cell culture
four replicates were performed. As a result for each ana-
lyzed combination set of twelve data were obtained and
analyzed statistically. The obtained values of adherences
are expressed as the percentage of mean value of adher-
ence present relative to the CHO-DAF+ positive control
assay, with a standard deviation because in this form they
are more meaningful and easier to compare with the pub-
lished data.
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The bacteria were cultivated on TSA plates either sup-
plemented or not with 3.5 mM pilicide, in exactly the
same way as for the CHO cells’ adherence assay. The
bacteria were scraped from the plates, washed and
suspended in PBS buffer to a final OD600 of 1.0. These
bacterial preparations were used in haemagglutination
assays in order to evaluate their level of fimbriation. The
human erythrocytes were prepared from blood group O,
the whole blood having been donated by a healthy vol-
unteer. The erythrocytes were washed three times with
PBS and then suspended in a PBS containing 2% D-
mannose to a final OD640 of 1.4. The serial dilutions of
the bacteria were prepared on 12-well microtitre plates.
The mannose resistant haemagglutination (MRHA)
assay was performed by adding an equal volume of the
erythrocyte suspension to the wells containing bacterial
serial dilutions. The haemagglutination experiments
were conducted on ice. The last well containing agglu-
tination was visually determined. The HA-titer denotes
the inverse of the latest bacterial dilution which still pro-
vides agglutination. To confirm that the agglutination
observed is an effect of the interaction between the Dr
fimbriae and DAF receptor, the reversibility of this reac-
tion as a consequence of chloramphenicol addition to a
2 μM final concentration was monitored. The HA-titers
were an average determined from duplicate runs in three
independent experiments.
Collagen binding assay
The wells of the polystyrene microtitre plate were coated
with type IV collagen from human placenta (Sigma) at a
concentration of 20 mg/ml and incubated at 4°C over-
night. They were then washed three times with PBS and
blocked with 1% BSA in PBS for 2 h at 37°C. After the
removal of the blocking buffer, 100 μl of bacterial cells
suspended in a PBS adjusted to a final OD600 of 1.0 were
added to the collagen-coated coverslips and incubated
for another 2 h at 37°C. Additionally, the bacterial prep-
arations were diluted 1:1, 1:2, 1:4, 1:6 and 1:8 in PBS.
The bacteria used in the assay were cultivated overnight
with shaking in the LB medium (5% DMSO, chloram-
phenicol), either supplemented or not with 0.5, 1.5, 2.5
and 3.5 mM pilicide 1 for 24 h at 37°C. The Dr fimbriae
of the bacteria bound to the collagen were detected with
rabbit polyclonal anti-Dr (Immunolab, Poland) and goat
anti-rabbit IgG-HRP (Sigma) antibodies at dilutions of
1:500 and 1:5000, with incubation for 40 min at 37°C,
respectively. All the antibodies were diluted in a PBS
containing 0.2% BSA. The bound antibodies were quan-
tified using Sigma Fast o-phenylenediamine substrate
(Sigma) as per manufacturer’s instructions, and mea-
sured in an ELISA plate reader (Victor3V, PerkinElmer)
at a 490 nm wavelength. The experiment was performedat least three times in duplicate using fresh bacterial
transformations and the mean value with standard devi-
ation was determined.
Densitometry analysis of SDS-PAGE resolved fimbrial
fractions
Dr fimbrial fractions were isolated from E. coli BL21DE3/
pBJN406 grown for 24h on TSA plates (5% DMSO, chlor-
amphenicol) in the presence of 0, 0.5, 1.5, 2.5 and 3.5 mM
pilicides 1 and 2. As a control experiment, a fimbrial frac-
tion was isolated from a non-fimbriated BL21DE3/
pACYC184 strain cultivated without pilicide. The bacterial
cells were centrifuged (14,000xg), resuspended in a PBS to
OD600 of 1.0 and vigorously vortexed for 15 min at ambi-
ent temperature. The cellular suspensions were then
centrifuged (14,000xg) and the supernatants containing
the bacterial fimbrial fractions were collected and stored
at 4°C. The same volumes (20 μl) of analyzed samples
were mixed with Laemmli sample buffer (5 μl), denatured
at 100°C for 60 min and ran in 15% (w/v) bis-acrylamide
gels containing SDS. To ensure that all the Dr fimbriae
were denatured to a monomeric DraE protein, a parallel
Western blotting with rabbit anti-Dr serum was con-
ducted. The proteins separated by gel electrophoresis were
visualized using Coomasie blue staining. The relative con-
centration of DraE protein in the fimbrial fractions was
determined by means of a densitometry analysis con-
ducted with an SDS-PAGE low-molecular-weight calibra-
tion kit (GE Healthcare, Little Chalfont, UK) as a
standard, using a VersaDoc system with Quantity One
software (both from Bio-Rad, Hercules, CA). The refer-
ence E. coli BL21DE3/pBJN406 grown without pilicide ar-
bitrary was set to 100%. The experiment was performed
three times using fresh bacterial transformations. The
summated optical density for the average of the analyzed
bands was densitometrically determined from the three
measurements for each experiment. For the technical rea-
sons only three experiments were performed and the
standard deviation of the mean value was not determined.
Results
Rationale for the choice of pilicides
To evaluate the potential of pilicide activity as blockers of
Dr fimbriae biogenesis, we used the published, di-
substituted 2-pyridones 1 and 2 (Figure 1) [22,31]. Pilicides
1 and 2 are derivatives of 2-pyridone with CH2-1-naphthyl
substituent at C-7 and cyclopropyl or phenyl at C-8 pos-
ition, respectively. The following aspects gave rise to the
choice of compounds 1 and 2 for our studies: 1) These
compounds belonging to the first generation of pilicides are
the most potent inhibitors of P and type 1 pili biogenesis
and were thus considered as lead compounds for further
structural modifications [34]; 2) There are many data de-
scribing activity of these compounds as blockers of P and
Figure 1 Blocking the adherence of E. coli Dr+ strain to CHO-DAF+ cells by pilicides. The propensity of bacteria binding to CHO-DAF+ and
CHO-DAF- cells was evaluated by staining with Giemsa (magnification x 10 000, Olympus CKX41 microscope). The following bacterial preparations
were used in the adherence assays: negative control – E. coli BL21DE3/pACYC184, grown on TSA plates with 5 % DMSO, non-fimbriated strain;
positive control - E. coli BL21DE3/pBJN406, grown on TSA plates without pilicide, fully-fimbriated strain; pilicide 1 and pilicide 2 - E. coli BL21DE3/
pBJN406 grown on TSA plates in the presence of 0.5, 1.5, 2.5 and 3.5 mM of agents 1 and 2, respectively. In the experiments presented by M and
N panels the E. coli BL21DE3/pBJN406 strain was grown in the presence of 3.5 mM of pilicides. The figure presents representative results obtained
from three independent experiments. Each experiment was composed from the four-fold repetition for each used bacterial preparation. The
bacterial adherence to 40 CHO cells was determined for each repetition. Presented in the figure pilicides 1 and 2 are the literature agents which,
at a 3.5 mM concentration, inhibit the assembly of FGS type 1 and P pili.
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bacterial cells, in vitro evaluation of pilicide affinity to the
chaperone molecules and crystallographic data describing
pilicide binding to the chaperone [21,23,24,34-36]; and 3)
The pilicides described so far were originally constructed
and subsequently modified on the basis of structural data
describing the PapD and FimC chaperones [22]. The use of
lead compounds 1 and 2 with undecorated C-2 and C-6
positions in experiments should give more general results
on pilicide activity against FGL-type adhesive organelles. In
our studies evaluating the anti-microbial activity of pilicides
1 and 2 as potential inhibitors of Dr fimbriae biogenesis, we
conducted whole bacteria cell experiments because, in con-
trast to in vitro protein – ligand assays, they generate morerelevant biological data. We used E. coli BL21DE3 strain
transformed with pBJN406 plasmid carrying the wild type
dra gene cluster in the experiments. This strain is routinely
used as the laboratory model of the clinical UPEC strain
IH11128 from which the dra operon was isolated [26,32].
For most in vivo experiments, the activity of pilicides 1 and
2 as inhibitors of type 1 and P pili formation was deter-
mined for the 3.5 mM pilicide concentration. In order to
perform a straight comparison with the published data, we
primarily analyzed the influence of pilicides on the Dr
fimbriae biogenesis using the 3.5 mM concentration and
exposed these data in the text. At this concentration, the
pilicides exerted a statistically unimportant effect on the
bacterial growth in comparison to the strain cultivated
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cordance with literature procedures [22,31].
Pilicides block Dr fimbriae-dependent bacterial adherence
At the first stage, we determined the adherence of bac-
teria cultivated on TSA plates in the presence of 0.5, 1.5,
2.5 and 3.5 mM of pilicides 1 and 2 to the CHO cells
transfected with plasmid encoding DAF receptor protein
recognized by Dr fimbriae. The process of bacteria at-
tachment was visualized by means of Giemsa staining.
In the case of strain BL21DE3/pBJN406 cultivated with-
out pilicide (positive control), we observed a high level
of bacteria attachment to the CHO-DAF+ cells related to
the undisturbed production of Dr fimbriae (Figure 1I).
The adherence of positive control is set as 100% ±12
and the observed adherences of all other used bacterial
preparations are expressed as the percentage of mean
value of adherence present relative to control. The
addition of 3.5 mM pilicide to the bacterial growth
media resulted in a very high reduction in the bacterial
adhesion properties: for pilicide 2, only a few bacterial
cells were visible as attached, corresponding to the rela-
tive bacterial adherence of 13% ±3 (Figure 1B) and for
pilicide 1 resulted in a slightly lower inhibition of bacter-
ial attachment, corresponding to the relative adherence
of 25% ±7 (Figure 1A). E. coli BL21DE3/pBJN406 bacter-
ial strains cultivated in the presence of 0.5, 1.5 and 2.5
mM of pilicides 1 and 2 showed dose dependent relative
adherence of: 90% ±3, 60% ±5 and 32% ±6 for pilicide 1
and 92% ±8, 42% ±7 and 21% ±9 for pilicide 2, respect-
ively (Figure 1 G,E,C and H,F,D). In order to confirm
that the bacterial adherence is dependent on the specific
interactions between the DraE fimbrial subunits and
DAF, we used as the control non-transfected CHO cells,
which do not express DAF molecules naturally. The
relative adherence of Dr-fimbriated BL21DE3/pBJN406
positive control (Figure 1J), non-fimbriated BL21DE3/
pACYC184 negative control (Figure 1L) and BL21DE3/
pBJN406 strain grown in the presence of 3.5 mM of
pilicide 1 or 2 (Figure 1M and N) to the CHO-DAF-
cells for all experiments was of 3-6% ± 1–2. The similar
value of relative adherence of 5% ±6 was determined for
binding of non-fimbriated BL21DE3/pACYC184 nega-
tive control strain to CHO-DAF+ cells. Statistical ana-
lysis confirmed the significance of decreased adherence
(p < 0.05) after the exposure of bacteria on different con-
centration of pilicides. Only the result for the lowest
concentration of pilicide 2 was statistically not signifi-
cant relatively to the positive control (p = 0.068). The in-
creasing concentration of pilicides also had the influence
on adhesion level (p < 0.05).
For further evaluation of the activity of compounds 1
and 2 as inhibitors of Dr fimbriae biogenesis, we used a
haemagglutination test (HA) conducted in a mannersimilar to the case of published data describing the activ-
ity of pilicides 1 and 2 as P and type 1 pili biogenesis in-
hibitors [34]. The assay is based on an analysis of human
erythrocyte agglutination mediated by the bacterial cells.
The reaction is dependent on the specific interaction be-
tween Dr fimbriae and DAF receptor located on the
erythrocyte surfaces. The interaction between DAF re-
ceptor and Dr fimbriae is inhibited by the addition of
chloramphenicol at a concentration of 2 μM [37]. The
specificity of the haemagglutination observed was con-
firmed by an analysis of its reversibility as a consequence
of the addition of chloramphenicol. The observed
haemagglutinating ability of the bacteria reflects the
amount of Dr fimbriae produced in the presence of the
pilicide. The HA-titer, the highest bacterial dilution, in
duplicates, which still provides erythrocyte agglutination
is determined in the experiment (Figure 2). A low HA-
titer indicates that a higher concentration of bacteria,
with low amount of fimbriae, is required for agglutin-
ation to occur. In our assay, the bacteria of E. coli
BL21DE3/pBJN406 were grown analogically to the CHO
cells adherence experiments, on agar plates containing
3.5 mM pilicide. The fully-fimbriated bacteria grown in
the absence of pilicide (positive control) resulted in an
HA-titer of 128. The non-fimbriated bacteria E. coli
BL21DE3/pACYC184 (negative control) gave an HA-
titer of 1. The bacteria cultivated in the presence of
pilicides 1 and 2 in media had a reduced HA-titer of 16/
32 (Figure 2). The HA-titers were determined as an
average from duplicate runs in three independent exper-
iments These results clearly show that bacteria grown in
the presence of these pilicides possess a reduced amount
of Dr fimbriae as an effect of blocking the chaperone-
usher pathway.
Pilicide-treated bacteria possess a reduced quantity of
Dr fimbriae
In order to monitor the effect of pilicides on the volume
of Dr fimbriae production quantitatively, we used two in-
direct assays; an ELISA, with anti-Dr antibodies, and a
densitometry analysis of fimbrial fractions resolved by
SDS-PAGE. Apart from interacting with DAF, the Dr fim-
briae also recognize type IV collagen as a receptor. In the
ELISA the wells of the polystyrene microtitre plate were
coated with type IV human collagen. After the blocking
step, different dilutions of bacteria were added and the
amount of Dr fimbriae was detected using rabbit anti-Dr
and anti-rabbit IgG-HRP antibodies. The bacteria E. coli
BL21DE3/pBJN406 and BL21DE3/pACYC184 were grown
in Luria-Bretani media because the assays performed on
bacteria scraped from agar result in a high background
during an ELISA test. Pilicide activity was only evaluated
for compound 1 at the concentration 0.5, 1.5, 2.5 and 3.5
mM, as pilicide 2 precipitates in LB medium containing
Figure 2 Blocking of Dr fimbriae-dependent agglutination of human erythrocytes by pilicides. The following bacterial preparations,
normalized to OD600, were used in the hemagglutination assays: negative control – E. coli BL21DE3/pACYC184, grown on TSA plates with 5%
DMSO, non-fimbriated strain; positive control - E. coli BL21DE3/pBJN406, grown on TSA plates without pilicide, fully-fimbriated strain;
chloramphenicol –E. coli BL21DE3/pBJN406, grown on TSA plates without pilicide, the agglutination experiment was performed in the presence
of 2 μM of chloramphenicol; pilicide 1 and pilicide 2 - the E. coli BL21DE3/pBJN406 grown on the TSA plates in the presence of 3.5 mM of agents
1 and 2, respectively. HA titer represents two-fold serial dilutions of normalized bacterial suspensions. The initial 1, 2 and final 128 dilutions are
not presented. In the case of HA assays with bacteria cultivated in media in the presence of pilicide the black triangles mark the highest dilution
which still provides visible agglutination.
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http://www.biomedcentral.com/1471-2180/13/1315% DMSO during cultivation. In experiments, the amount
of Dr fimbriae for strain E. coli BL21DE3/pBBJN406
grown in the presence of 0.5, 1.5, 2.5 and 3.5 mM pilicide
1 was reduced by 3%, 45% 74% and 81%, respectively in
relation to the same bacteria grown without pilicide
(Figure 3D). Decreasing of Dr fimbriae amount caused
only by 0.5 mM pilicide dilution was not statistically sig-
nificant (p = 0.625), higher concentrations provided p-
value much below 0.05. Also increasing concentration of
pilicides was statistically significant for Dr fimbriae
amount reduction (p < 0.05).
To further evaluate the effect of pilicides on the inhibition
of Dr fimbriae production, we quantified the amount of
monomeric DraE protein resulting from the denaturation/
depolimerization of isolated Dr fimbriae samples using a
densitometric analysis of the SDS-PAGE gels stained with
Coomassie Blue (Figure 3A-C). The strain E. coli BL21DE3/
pBJN406 was grown on agar plates supplemented with
pilicides 1 and 2 at a concentration of 0.5, 1.5, 2.5 and 3.5mM. Non-fimbriated E. coli BL21DE3/pACYC184 and
fully-fimbriated BL21DE3/pBJN406 strains grown without
pilicide were used as the negative and positive controls, re-
spectively. The fimbriae from the bacteria scraped and nor-
malized to OD600 were isolated by means of vortexing.
Dr fimbriae are very stable structures which require
extending heating in Laemmli buffer in order to depo-
limerize to a monomeric DraE protein. The band of mono-
meric DraE protein was visible in resolved samples heated
for 60 min at 100°C before electrophoresis. In contrast,
there was no band corresponding to monomeric DraE in
the samples which had not been denatured thermally before
electrophoresis (Figure 3A). This confirms that the isolated
fractions only contained Dr fimbriae and were not contami-
nated by the monomeric, periplasmic form of DraE protein.
In order to prove that the heating time for the samples is
sufficient for the total denaturation of Dr fimbrial structures
to monomeric DraE, we performed a Western blotting
analysis with anti-Dr antibodies (Figure 3B). In these
Figure 3 Relative determination of Dr fimbriae amount on bacteria treated with pilicides. (A) SDS-PAGE analysis of the fimbrial fractions
isolated from the following bacterial cultures: lanes 1,5 - BL21DE3/pBJN406, grown on TSA plates without the pilicide, fully-fimbriated strain;
2,6 - BL21DE3/pACYC184, non-fimbriated strain; 3,7 and 4,8 - BL21DE3/pBJN406, grown in the presence of 3.5 mM of agents 1 and 2, respectively.
Before electrophoresis, the samples from 1 to 4 and from 5 to 8 were incubated for 60 min at 100°C and 25°C, respectively. M – the SDS-PAGE
LMW Calibration Kit weight standard. Arrow denoted monomeric DraE protein. (B) Western blotting analysis of the fimbrial fractions, performed
to confirm the complete depolymerization of Dr fimbriae during sample denaturation. 1,2,3 – the same samples as in lanes 2,1 and 5 in panel B,
respectively. (C) SDS-PAGE analysis of fimbrial fractions isolated from E. coli BL21DE3/pBJN406 grown on TSA plates supplemented with different
concentrations of pilicide 1 (Pil1) and pilicide 2 (Pil2). Densitometrically evaluated DraE amounts are expressed as the percentage of mean value
present relative to bacterial strain cultivated without pilicide, arbitrary set to 100%: 0.5 mM – 92 and 97%; 1.5 mM – 45 and 55%; 2.5 mM – 32
and 25%; 3.5 mM – 25 and 20% for strains grown in the presence of pilicide 1 and 2, respectively. (D) Evaluation of bacteria fimbriation using an
ELISA assay with microtitre plates coated with type IV human collagen. The Dr fimbriae exposed on the bacteria adhered to collagen were
visualized using anti-Dr antibodies. The following bacterial preparations were used in the assay: 1 - BL21DE3/pACYC184, non-fimbriated strain;
2-5 - BL21DE3/pBJN406, grown in LB medium supplemented with 3.5, 2.5, 1.5 and 0.5 mM of agent 1, respectively; 6 - BL21DE3/pBJN406, grown
in LB medium without the pilicide, fully-fimbriated strain. The bars represent the s.d. of the mean of three independent experiments in duplicate.
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and 2 were comparable (Figure 3C). For bacteria cultivated
in the presence of 3.5 mM of pilicides 1 and 2, the amount
of DraE fimbrial protein was reduced by 75 and 80% in
comparison to the fully-fimbriated strain grown without
pilicide, respectively. Performing experiments with 0.5, 1.5
and 2.5 mM concentration of pilicides, we analyzed their
dose dependent effects on the volume of fimbrial produc-
tion. At a concentration of 2.5 mM, pilicides 1 and 2 inhibit
fimbrial production at comparable level as in the case of
bacteria treated with the 3.5 mM concentration, –
adherence reduction by 68 and 75%, respectively. The use
of pilicides 1 and 2 at a concentration of 1.5 mM results in
a relative DraE reduction of 55 and 45%, respectively. Bac-
teria cultivated with 0.5 of pilicides 1 and 2 have almost the
same amount of the DraE protein derived from Dr fimbriae
as in the case of strain grown without the addition of the
compounds, – adherence reduction 8 and 3%, respectively.Discussion
The anti-bacterial activity of pilicides has only been con-
firmed in the case of uropathogenic E. coli producing type
1 and P pili which represent the FGS type organelles. In
this paper for the first time we investigated the activity of
pilicides as inhibitors of the FGL-type adhesion structure
biogenesis using as a model Dr fimbriae. The sequence
and structural analyses of the DraB chaperone (PDB ID:
4DJM) reveal that it possesses all the marks characteristic
for the FGL Caf1M-like chaperones (Figure 4A): 1) the
β-strands F1 and G1 are connected by the long loop,
which is composed of 15 residues; 2) the G1 donor strand
contains five bulky hydrophobic residues; 3) the N-
terminal subunit binding motif including the β-strand A1
with three bulky hydrophobic residues is very long and
contains 26 residues, whereas the PapD has only 7 resi-
dues, 2 of them bulky hydrophobic; 4) the conserved
disulfide bond stabilizes a massive F1-loop-G1 hairpin;
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W110, are located in the loop connecting the β-strands F1
and G1 [12,13]. The X-ray structures published showing
the structure of a pilicide interacting with the free PapD
chaperone revealed that the ligand affects the hydrophobic
patch located in the F1-C1-D1 β-sheet of the N-terminal
domain formed by the residues I93, L32 and V56 [23,24].
An homologous motif, which could, presumably be a
pilicide binding site, is also present in the structure of the
DraB chaperone and encompasses residues L53, L75 and
I110. The geometry of this region is very similar to that
observed in the PapD protein (Figure 4B). The structuralFigure 4 DraB as a model of the FGL subfamily of chaperones. (A) Ch
the FGL chaperones in relation to the PapD (PDB ID: 2WMP), - the represen
residues participating in subunit interaction represented in the bonds mod
β-strand A1 characteristic for FGL chaperones observed in the DraB is deno
in green with the alternating hydrophobic residues of the β-strand G1 part
F1-G1 loop of the DraB protein, the conserved residue motif KDW characte
disulfide bond binding β-strands F1 and G1 in the DraB structure conserve
F1-G1 loop region was modeled using MODELLER v9.2 software. (B) Structu
(PDB ID: 2J7L) (blue) with denoted hydrophobic patch that includes I93, L3
binding motif. At the beginning of the F1-G1 loop the region of two prolin
chaperones is denoted (P111 and P112 in the DraB – yellow; P94 and P95analysis of DraB allows us to treat it as a model represen-
tative of a sub-family of the FGL-like chaperones.
Activity of pilicides 1 and 2 as inhibitors of Dr fim-
briae biogenesis was tested on the E. coli BL21DE3/
pBJN406 – the laboratory model of the clinical UPEC
IH11128 strain. Biological evaluations based on the
whole-cell assays were predominantly performed using a
3.5 mM concentration of pilicides, as is used in the case
of most experiments with an inhibition of type 1 and P
pili formation. The E. coli BL21DE3/pBJN406 bacteria
cultivated in the presence of 3.5 mM pilicides 1 and 2
showed the amount of DraE subunits/Dr fimbriaearacteristic elements of the DraB structure (PDB ID: 4DJM) specific to
tative of the FGS subfamily. The part of β-strand A1 with hydrophobic
e is denoted in red. The fragment of the long N-terminal region of the
ted in yellow. The F1 strand-loop-G1 strand hairpin motif is denoted
icipating in the DSC reaction denoted in the bonds mode. In the
ristic for FGL chaperones are marked with the bond mode. The
d in the entire FGL subfamily is marked in yellow bond mode. The
ral alignment of the usher binding site of DraB (red) and PapD-pilicide
2, V56 (PapD) and I110, L56, L32 (DraB) residues forming pilicide (pink)
e residues forming “proline lock” conserved in the family of
in the PapD - green).
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tometry analysis of isolated fimbrial fractions. A Western
immunoblot analysis of this strain with anti-Dr anti-
bodies denoted a reduction, by 81%, of the amount of
Dr fimbriae in relation to fully-fimbriated, pilicide un-
treated bacteria. The amounts of major pili P PapA (re-
combinant strain HB101/pPAP5) and type 1 pili FimA
(clinical strain UTI89) subunits isolated from bacteria
cultivated in the presence of 3.5 mM of pilicide 1 ana-
lyzed by immunoblot were reduced by 68% and 53%,
respectively [23,36]; in the case of FimA, the C-6
morpholinomethyl substituent in pilicide 1 with no ef-
fects on its biological activity was compared. The atomic
force microscopy analysis of the HB101/pPAP5 strain
showed that the bacteria treated with 3.5 mM of pilicide
1 were devoid of P pili [36]. The inhibition of Dr fim-
briae production by 3.5 mM pilicides 1 and 2 is reflected
in the 25% ± 7 and 13 ±3% DAF dependent bacteria rela-
tive adherence to CHO cells, respectively. This correlates
well with the 90% reduction in adherence to the bladder
cells of E. coli NU14 producing type 1 pili cultivated in
the presence of a C-6 morpholinomethyl derivative of
pilicide 1 [23]. In the haemaglutynation assay, which also
reflects the adherence properties of E. coli BL21DE3/
pBJN406 Dr+ strain treated with 3.5 mM pilicides 1 and
2, we observed an HA-titer of 16/32; the strain un-
treated with pilicide constituting the control has an HA-
titer of 128. Published HA-titer data for the HB101/
pPA5A strain, treated and untreated with pilicide 1, are
1/4 and 128, respectively [34,36]. The difference ob-
served in the HA-titer of the pilicide-treated Dr- and pili
P-producing strains is difficult to analyze because of ex-
perimental reasons. We only presumed that the higher
haemagglutination properties of Dr fimbriae-producing
bacteria might be connected with the polyadhesin nature
of these structures, in contrast to the monoadhesin of P
pili. As the DraE subunits are multi-receptor adhesins,
the inhibition of Dr fimbriae assembly by pilicides was
also confirmed by the evaluation of bacterial adherence
to the type IV human collagen receptor. The SDS-PAGE
analysis of isolated fimbrial fractions, collagen binding
assay and Dr fimbriae dependent bacterial adherence to
CHO-DAF+ cells assay performed using bacteria culti-
vated in the 0, 0.5, 1.5, 2.5 and 3.5 mM of compounds 1
and 2 confirmed that the effect of Dr fimbriae assembly
inhibition observed was dependent on the pilicide con-
centration used. This is a crucial feature of the antibac-
terial agents. The data based on the whole cell assays
presented in this article confirm that pilicides effectively
inhibit the receptor-dependent adherence of E. coli Dr+
strain to the host cells. Thus pilicides impair the crucial
step of bacterial pathogenesis, namely, – the formation
of initial, close contact between bacteria and host cell.
The evaluations of the pilicides’ effects on E. coli Dr+strain are comparable to those previously published for
type 1- and P pili-producing bacteria. This suggests
that the structural and functional differences observed
between FGS and FGL chaperone-usher systems are not
crucial to pilicide activity. This thesis is supported by the
structure of the Caf1-Caf1M subunit-chaperone pre-
assembly complex bound to the N-terminal domain of
Caf1A usher – the example of the FGL system [11]. Al-
though Caf1A and FimD belong to the FGL and FGS
subfamilies of usher respectively, their N-terminal do-
mains represents a high degree of structural similarity.
The structures of usher binding sites that encompass
pilicide binding residues are also highly conserved in the
FGL and FGS type chaperones (Figure 4B). Comparison
of the free Caf1M and Caf1-Caf1M complex structures
permits to identify in the usher binding site of Caf1M
chaperone specific “proline lock” that by interaction with
Caf1 subunit allostericaly controls the chaperone-usher
pathway [11]. Such ”proline lock” was also identified in
the available sequences and structures of usher binding
sites of the other FGS and FGL type chaperones includ-
ing DraB (Figure 4B) [11]. This clearly shows that inter-
action between N-terminal domain of usher and usher
binding motif of chaperones is highly conserved struc-
turally and mechanically.
Conclusions
We conclude that pilicides 1 and 2 in mM concentration
effectively inhibit the adherence of the laboratory model
of uropathogenic E. coli Dr+ strain, - the main causative
agent of cystitis and pyelonephritis in pregnant women,
to the host cell DAF and collagen receptors by blocking
the assembly of Dr fimbriae. On the basis of the high
conservation of the Dr family of adhesins, which include
clinically important human UPEC strains, we deduce
that the pilicides should also effectively inhibit their as-
sembly and, more speculatively, other FGL adhesive
structures. The earlier thesis proposed by pilicide origi-
nators: “Pilicides, by blocking chaperone and usher func-
tion, have the potential to inhibit pili formation in a
broad spectrum of pathogenic bacteria to prevent critical
host-pathogen interactions necessary for many diseases
[23]” has been considerably reinforced experimentally by
extending the examination of pilicide activity from FGS-
type structures to the assembly of FGL-type Dr fimbriae.
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